Biomarker predicts resistance to checkpoint inhibitor drugs for treatment of melanoma Dr. Kamal Kant Kohli26 Nov 2022 2:30 AM GMTDuke Cancer Institute researchers have identified potential biomarkers that predict the likelihood for checkpoint inhibitor drugs to backfire, driving...
Exercise can reduce severity of side effects of breast cancer treatment Dr. Kamal Kant Kohli21 Nov 2022 2:30 PM GMTBreast cancer is the most common form of the disease among women; in Australia, one in eight women will be diagnosed with breast cancer by the age of...
Medical Bulletin 21/November/2022 Dr. Nandita Mohan21 Nov 2022 11:00 AM GMTHere are the top medical news for the day:Novel device measures nerve activity that may help treatment sepsis and PTSDSepsis is the body's extreme...
Myocarditis in cancer patients is driven by specific immune cells Dr. Nandita Mohan21 Nov 2022 4:00 AM GMTMyocarditis is an inflammatory process of the myocardium. In most of the developed countries, viral infections are most frequently the cause of...
AP Govt, NatHealth join hands to work in healthcare sector Adity Saha16 Nov 2022 10:30 AM GMTBoth parties have decided to work towards comprehensive cancer prevention, early & complete diagnosis, treatment, and care program and implementation...
Shortened course of radiation therapy safe and effective for men with high-risk prostate cancer Dr. Kamal Kant Kohli12 Nov 2022 4:15 AM GMTA new randomized study confirms that men with high-risk prostate cancer can be treated with five versus eight weeks of radiation therapy. The phase...
Adding radiation to hormone therapy may slow growth of Oligometastatic Prostate Cancer Dr. Kamal Kant Kohli10 Nov 2022 2:30 PM GMTResearchers have found in a new study that addition of radiation to hormone therapy may slow growth of Oligometastatic Prostate Cancer and improve...
Jamshedpur: Meherbai Tata Memorial Hospital to get 4-bed ICU on December 22 Adity Saha10 Nov 2022 4:30 AM GMT"We would also start Lutetium therapy at MTMH by this year-end for prostate cancer patients who have not responded to conventional treatment. This...
AI may help identify melanoma survivors at high risk of cancer recurrence Dr. Kamal Kant Kohli2 Nov 2022 11:30 PM GMTMost deaths from melanoma-the most lethal form of skin cancer-occur in patients who were initially diagnosed with early-stage melanoma and then later...
Targeted lung cancer drug repotrectinib shows promise in TRIDENT-1 trial Dr. Kamal Kant Kohli28 Oct 2022 11:15 PM GMTResearchers have found in TRIDENT-1 trial that targeted drug repotrectinib could help treat patients with a certain type of non-small cell lung...
Medical Bulletin 28/October/2022 Isra Zaman28 Oct 2022 11:30 AM GMTHere are the top medical news for the day:Specific alterations in the BRAF gene found that may affect treatment and survival response in adult brain...
Olaparib and adavosertib, work best when given sequentially in patients with advanced tumours: results from Phase Ib STAR clinical trial Isra Zaman28 Oct 2022 4:30 AM GMTPresenting results from the phase Ib STAR clinical trial to the 34th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics in...
